株式会社グローバルインフォメーション
TEL: 044-952-0102
表紙
市場調査レポート

オメガ3脂肪酸の世界市場:市場規模、シェア、動向分析 - 用途(栄養補助食品 & 機能性食品、ペットフード & 飼料、医薬品、乳児用調製粉乳)別 2019年〜2025年

Omega 3 Market Size, Share & Trends Analysis Report By Application (Supplements & Functional Foods, Pet & Animal Feed, Pharmaceuticals, Infant Formulas), By Region (North America, APAC), And Segment Forecasts, 2019 - 2025

発行 Grand View Research, Inc. 商品コード 818735
出版日 ページ情報 英文 100 Pages
納期: 2-3営業日
価格
本日の銀行送金レート: 1USD=109.52円で換算しております。
Back to Top
オメガ3脂肪酸の世界市場:市場規模、シェア、動向分析 - 用途(栄養補助食品 & 機能性食品、ペットフード & 飼料、医薬品、乳児用調製粉乳)別 2019年〜2025年 Omega 3 Market Size, Share & Trends Analysis Report By Application (Supplements & Functional Foods, Pet & Animal Feed, Pharmaceuticals, Infant Formulas), By Region (North America, APAC), And Segment Forecasts, 2019 - 2025
出版日: 2019年03月28日 ページ情報: 英文 100 Pages
概要

オメガ3脂肪酸の世界市場は、2019年から2025年にかけて7.4%のCAGRで推移し37億7,000万米ドル規模の市場に成長することが予測されています。医薬品原薬(API)へのオメガ3脂肪酸の利用の増加が当市場の主な成長要因となっています。また、新興地域、特にアジア太平洋地域で顕著な人口増加も市場の成長を促進しています。

当レポートでは、オメガ3脂肪酸の世界市場を調査し、市場の概要、用途・地域別の市場規模の推移と予測、市場の成長要因および阻害要因の分析、競合情勢、主要企業のプロファイルなど、包括的な情報を提供しています。

目次

第1章 調査手法と範囲

  • 情報調達
  • 情報分析とデータ分析モデル

第2章 エグゼクティブサマリー

第3章 市場変数、傾向、範囲

  • 市場の見通し
  • 浸透および成長の見通しのマッピング
  • バリューチェーン分析
  • オメガ3脂肪酸の分析
  • 技術の概要
  • 規制の枠組み
  • 市場力学
  • ビジネス環境分析
  • 市場参入戦略

第4章 オメガ3脂肪酸市場の分析と予測:用途別

  • 定義と範囲
  • 市場動向と市場シェア:用途別
  • 栄養補助食品・機能性食品
  • 医薬品
  • 乳児用調製粉乳
  • ペットフード & 飼料
  • その他

第5章 オメガ3脂肪酸市場の分析と予測:地域別

  • 市場スナップショット:地域別
  • SWOT分析:地域別
    • 北米
    • 欧州
    • アジア太平洋地域
    • 中南米
    • 中東・アフリカ
  • 北米
    • 米国
  • 欧州
    • 英国
    • ドイツ
  • アジア太平洋地域
    • インド
    • 中国
    • 日本
  • 中南米
    • ブラジル
  • 中東・アフリカ

第6章 競争分析

  • 主要企業の最近の動向とその影響
  • 企業区分(イノベーター、マーケットリーダー、新興企業)
  • 競合情勢
  • 公営企業
  • 民間企業

第7章 企業プロファイル

  • Aker BioMarine
  • Axellus
  • BASF
  • DSM
  • Omega Protein Corporation
  • GC Reiber Oils
  • Lonza
  • Martek Biosciences Corporation.
  • Pronova BioPharma
  • Croda
  • EPAX
  • BioProcess Algae
図表

List of Tables

  • Table 1 Global Omega 3 market estimates and forecasts in supplement & functional foods, 2014 - 2025 (Tons) (USD Million)
  • Table 2 Global Omega 3 market estimates and forecasts in pharmaceuticals, 2014 - 2025 (Tons) (USD Million)
  • Table 3 Global Omega 3 market estimates and forecasts in infant formulas, 2014 - 2025 (Tons) (USD Million)
  • Table 4 Global Omega 3 market estimates and forecasts in pet & animal feed, 2014 - 2025 (Tons) (USD Million)
  • Table 5 Global Omega 3 market estimates and forecasts in others, 2014 - 2025 (Tons) (USD Million)
  • Table 6 North America omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 7 North America omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 8 North America omega 3 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
  • Table 9 U.S. omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 10 U.S. omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 11 U.S. omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 12 Europe omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 13 Europe omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 14 Europe omega 3 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
  • Table 15 U.K. omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 16 U.K. omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 17 U.K. omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 18 Germany omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 19 Germany omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 20 Germany omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 21 Asia Pacific omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 22 Asia Pacific omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 23 Asia Pacific omega 3 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
  • Table 24 India omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 25 India omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 26 India omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 27 China omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 28 China omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 29 China omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 30 Japan omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 31 Japan omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 32 Japan omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 33 Central & South America omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 34 Central & South America omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 35 Central & South America omega 3 market estimates and forecasts, by application, 2014 - 2025 (USD Million)
  • Table 36 Brazil omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 37 Brazil omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 38 Brazil omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 39 Middle East & Africa omega 3 market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
  • Table 40 Middle East & Africa omega 3 market estimates and forecasts, by application, 2014 - 2025 (Tons)
  • Table 41 Middle East & Africa omega 3 market estimates and forecasts, by application, 2014 - 2025 (USD Million)

List of Figures

  • Fig. 1 Information procurement
  • Fig. 2 Primary research pattern
  • Fig. 3 Primary research process
  • Fig. 4 Primary research approaches
  • Fig. 5 Omega 3 market: Segmental snapshot
  • Fig. 6 Omega 3 market: Competitive snapshot
  • Fig. 7 Omega 3 market: Penetration & growth prospect mapping
  • Fig. 8 Value chain analysis
  • Fig. 9 Manufacturing process
  • Fig. 10 Sales channel analysis
  • Fig. 11 Product and key strategic developments timeline
  • Fig. 13 Product cost in USD
  • Fig. 14 Porters five forces analysis
  • Fig. 15 PESTEL Analysis
  • Fig. 16 Omega 3 market, application movement analysis, 2018 & 2025
  • Fig. 17 Omega 3 market, regional movement analysis, 2018 & 2025
目次
Product Code: 978-1-68038-079-8

The global omega 3 market size is projected to reach USD 3.77 billion by 2025 registering a CAGR of 7.4%, according to a new report by Grand View Research, Inc. Rising product usage in the Active Pharmaceutical Ingredient (API) market is among the major driving factors for the omega 3 market. Moreover, rising population in emerging regions, most notably in Asia Pacific, has complemented the growth of this market. In addition, technological advancements pertaining to the manufacturing of APIs among other highly potent active ingredients will drive the market further.

In addition, rapid growth of the dietary supplements market is projected to bolster the product demand. Omega 3 is being increasingly used in the dietary supplements as it can significantly reduce the risk of cardiovascular and heart diseases. Moreover, it can also reduce the risk of arrhythmias or abnormal heartbeats. Furthermore, it helps slow down the growth of atherosclerotic plaque while lowering the levels of blood pressure. In addition, rising disposable incomes, especially in middle class population in emerging economies of China and India, will augment the demand further.

North America emerged as the largest market in 2018 due increased focus on R&D activities for developing various grades of the product, especially pharma-grade omega 3 for enhanced medication to prevent chronic diseases. However, Asia Pacific is expected to witness the fastest CAGR over the forecast period. Ongoing advancements in the food industry and medical science coupled with demographic changes and high consumer demand are expected to provide impetus for the regional market growth.

Further key findings from the study suggest:

  • Supplements & functional foods emerged as the largest application segment in 2018 and is expected to register a CAGR of 7.3% over the forecast period
  • Led by emerging economies like India, China, and Japan, Asia Pacific is expected to witness the fastest growth over the forecast period
  • The market is characterized by intense competition among international and domestic companies. Thus, mots companies have undertaken M&A as their key strategy to withstand the competition
  • Furthermore, product innovation has also been a preferred strategic initiative by prominent manufacturers

Some of these key market participants include: Aker BioMarine, Axellus, BASF SE, DSM, Omega Protein Corp., GC Rieber Oils AS, Martek Biosciences Corp., and Lonza Group

Table of Contents

Chapter 1 Methodology and Scope

  • 1.1 Information Procurement
    • 1.1.1 Purchased Database
    • 1.1.2 GVR's Internal Database
    • 1.1.3 Secondary Sources
    • 1.1.4 Third Party Perspective
    • 1.1.5 Primary Research
  • 1.2 Information Analysis & Data Analysis Models

Chapter 2 Executive Summary

  • 2.1 Market Insights
  • 2.2 Segmental Insights
  • 2.3 Competitive Insights

Chapter 3 Market Variables, Trends & Scope

  • 3.1 Market Lineage Outlook
    • 3.1.1 Parent Market Outlook
    • 3.1.2 Related Market Outlook
  • 3.2 Penetration & Growth Prospect Mapping
  • 3.3 Value Chain Analysis
    • 3.3.1 Raw Material Trends
      • 3.3.1.1 Major Raw Material Analysis
      • 3.3.1.2 Procurement Best Practices
    • 3.3.2 Manufacturing trends
      • 3.3.2.1 Technology Trends
      • 3.3.2.2 Outsourcing and contract manufacturing trends
    • 3.3.3 cost structure and profit margin analysis
      • 3.3.3.1 Average Selling Price Analysis
      • 3.3.3.2 Profit margin and cost analysis
    • 3.3.4 sales channel analysis
    • 3.3.5 Vendor selection criteria
  • 3.4 Omega 3 Analysis
    • 3.4.1 New Products
    • 3.4.2 Product Campaign Information
  • 3.5 Technology Overview
    • 3.5.1 technology timeline
  • 3.6 Regulatory Framework
  • 3.7 Market Dynamics
    • 3.7.1 Market Driver Analysis
      • 3.7.1.1 Rising penetration of Omega 3 in Active Pharmaceutical Ingredient market
      • 3.7.1.2 Growing dietary supplements market
    • 3.7.2 Market restraint Analysis
      • 3.7.2.1 Declining growth rate of fish production
      • 3.7.2.1 Restricted supply of alternative sources
    • 3.7.3 Industry challenges
  • 3.8 Business Environment Analysis
    • 3.8.1 Porter's Analysis
      • 3.8.1.1 Threat of new entrants
      • 3.8.1.2 Bargaining power of suppliers
      • 3.8.1.3 Bargaining power of buyers
      • 3.8.1.4 Threat of substitutes
      • 3.8.1.5 Competitive rivalry
    • 3.8.2 PESTLE Analysis
      • 3.8.2.1 Political Landscape
      • 3.8.2.2 Environmental Landscape
      • 3.8.2.3 Social Landscape
      • 3.8.2.4 Technology Landscape
      • 3.8.2.5 Economic Landscape
      • 3.8.2.6 Legal Landscape
    • 3.8.3 Major Deals & Strategic Alliances Analysis
      • 3.8.3.1 Mergers & AcquIsitions
      • 3.8.3.2 Licensing & partnership
  • 3.9 Market Entry Strategy

Chapter 4 Omega 3 Market: Application Estimates & Trend Analysis

  • 4.1 Definitions & Scope
  • 4.2 Application movement & market share analysis, 2018 & 2025
  • 4.3 Supplement & functional foods
    • 4.3.1 Market Estimates And Forecasts In Supplement & Functional Foods, 2014 - 2025 (Tons) (USD Million)
  • 4.4 Pharmaceuticals
    • 4.4.1 Market Estimates And Forecasts In Pharmaceuticals, 2014 - 2025 (Tons) (USD Million)
  • 4.5 Infant formulas
    • 4.5.1 Market Estimates And Forecasts In Infant Formulas, 2014 - 2025 (Tons) (USD Million)
  • 4.6 Pet & animal feed
    • 4.6.1 Market Estimates And Forecasts In Pet & Animal Feed, 2014 - 2025 (Tons) (USD Million)
  • 4.7 Others
    • 4.7.1 Market Estimates And Forecasts In Others, 2014 - 2025 (Tons) (USD Million)

Chapter 5 Omega 3 Market: Regional Estimates & Trend Analysis

  • 5.1 Regional Market Snapshot
    • 5.1.1 Regional movement & market share analysis, 2018 & 2025
  • 5.2 SWOT Analysis, by Region
    • 5.2.1 North America
    • 5.2.2 Europe
    • 5.2.3 Asia Pacific
    • 5.2.4 Central & SOuth America
    • 5.2.5 Middle East & Africa
  • 5.3 North America
    • 5.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
    • 5.3.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
    • 5.3.3 U.S.
      • 5.3.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.3.3.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
  • 5.4 Europe
    • 5.4.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
    • 5.4.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
    • 5.4.3 U.K.
      • 5.4.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.4.3.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
    • 5.4.4 Germany
      • 5.4.4.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.4.4.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
  • 5.5 Asia Pacific
    • 5.5.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
    • 5.5.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
    • 5.5.3 India
      • 5.5.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.5.3.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
    • 5.5.4 China
      • 5.5.4.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.5.4.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
    • 5.5.5 Japan
      • 5.5.5.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.5.5.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
  • 5.6 Central & South America
    • 5.6.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
    • 5.6.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
    • 5.6.3 Brazil
      • 5.6.3.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.6.3.2 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)
  • 5.7 Middle East & Africa
    • 5.7.1 Market estimates and forecasts, 2014 - 2025 (Tons) (USD Million)
      • 5.7.1.1 Market estimates and forecasts, by Application, 2014 - 2025 (Tons) (USD Million)

Chapter 6 Competitive Analysis

  • 6.1 Key Players' Recent Developments & Their Impact
  • 6.2 Key Innovators, Market Leader, and Emerging Players
  • 6.3 Vendor Landscape
    • 6.3.1 List of key distributors & channel partners
    • 6.3.2 Key customers
  • 6.4 Public Companies
    • 6.4.1 Company market position analysis
    • 6.4.2 Company ranking
    • 6.4.3 Competitive dashboard analysis
    • 6.4.4 Market differentiators
    • 6.4.5 Synergy Analysis: Major Deals & Strategic Alliances
    • 6.4.6 SWOT Analysis of Public companies
  • 6.5 Private Companies
    • 6.5.1 List of key emerging companies/technology disruptors/innovators
    • 6.5.2 Geographical Presence
    • 6.5.3 Company market position analysis

Chapter 7 Company Profiles

  • 7.1 Aker BioMarine
    • 7.1.1 Company Overview
    • 7.1.2 Financial Performance
    • 7.1.3 Product Benchmarking
    • 7.1.4 Strategic Initiatives
  • 7.2 Axellus
    • 7.2.1 Company Overview
    • 7.2.2 Financial Performance
    • 7.2.3 Product Benchmarking
    • 7.2.4 Strategic Initiatives
  • 7.3 BASF
    • 7.3.1 Company overview
    • 7.3.2 Financial Performance
    • 7.3.3 Product Benchmarking
  • 7.4 DSM
    • 7.4.1 Company Overview
    • 7.4.2 Financial Performance
    • 7.4.3 Product Benchmarking
    • 7.4.4 Strategic Initiatives
  • 7.5 Omega Protein Corporation
    • 7.5.1 Company Overview
    • 7.5.2 Financial Performance
    • 7.5.3 Product Benchmarking
    • 7.5.4 Strategic Initiatives
  • 7.6 GC Reiber Oils
    • 7.6.1 Company Overview
    • 7.6.2 Financial Performance
    • 7.6.3 Product Benchmarking
    • 7.6.4 Strategic Initiatives
  • 7.7 Lonza
    • 7.7.1 Company Overview
    • 7.7.2 Financial Performance
    • 7.7.3 Product Benchmarking
    • 7.7.4 Strategic Initiatives
  • 7.8 Martek Biosciences Corporation.
    • 7.8.1 Company Overview
    • 7.8.2 Financial Performance
    • 7.8.3 Product Benchmarking
    • 7.8.4 Strategic Initiatives
  • 7.9 Pronova BioPharma
    • 7.9.1 Company Overview
    • 7.9.2 Financial Performance
    • 7.9.3 Product Benchmarking
    • 7.9.4 Strategic Initiatives
  • 7.10 Croda
    • 7.10.1 Company Overview
    • 7.10.2 Financial Performance
    • 7.10.3 Product Benchmarking
  • 7.11 EPAX
    • 7.11.1 Company Overview
    • 7.11.2 Financial Performance
    • 7.11.3 Product Benchmarking
    • 7.11.4 Strategic Initiatives
  • 7.12 BioProcess Algae
    • 7.12.1 Company Overview
    • 7.12.2 Financial Performance
    • 7.12.3 Product Benchmarking
    • 7.12.4 Strategic Initiatives
Back to Top